Sultana Rukhsana, Ravagna Agrippino, Mohmmad-Abdul Hafiz, Calabrese Vittorio, Butterfield D Allan
Department of Chemistry, University of Kentucky, Lexington, KY 40506, USA.
J Neurochem. 2005 Feb;92(4):749-58. doi: 10.1111/j.1471-4159.2004.02899.x.
Alzheimer's disease (AD) is neuropathologically characterized by depositions of extracellular amyloid and intracellular neurofibrillary tangles, associated with loss of neurons in the brain. Amyloid beta-peptide (Abeta) is the major component of senile plaques and is considered to have a causal role in the development and progress of AD. Several lines of evidence suggest that enhanced oxidative stress and inflammation play important roles in the pathogenesis or progression of AD. The present study aimed to investigate the protective effects of ethyl-4-hydroxy-3-methoxycinnamic acid (FAEE), a phenolic compound which shows antioxidant and anti-inflammatory activity, on Abeta(1-42)-induced oxidative stress and neurotoxicity. We hypothesized that the structure of FAEE would facilitate radical scavenging and may induce protective proteins. Abeta(1-42) decreases cell viability, which was correlated with increased free radical formation, protein oxidation (protein carbonyl, 3-nitrotyrosine), lipid peroxidation (4-hydroxy-2-trans-nonenal) and inducible nitric oxide synthase. Pre-treatment of primary hippocampal cultures with FAEE significantly attenuated Abeta(1-42)-induced cytotoxicity, intracellular reactive oxygen species accumulation, protein oxidation, lipid peroxidation and induction of inducible nitric oxide synthase. Treatment of neurons with Abeta(1-42) increases levels of heme oxygenase-1 and heat shock protein 72. Consistent with a cellular stress response to the Abeta(1-42)-induced oxidative stress, FAEE treatment increases the levels of heme oxygenase-1 and heat shock protein 72, which may be regulated by oxidative stresses in a coordinated manner and play a pivotal role in the cytoprotection of neuronal cells against Abeta(1-42)-induced toxicity. These results suggest that FAEE exerts protective effects against Abeta(1-42) toxicity by modulating oxidative stress directly and by inducing protective genes. These findings suggest that FAEE could potentially be of importance for the treatment of AD and other oxidative stress-related diseases.
阿尔茨海默病(AD)的神经病理学特征是细胞外淀粉样蛋白沉积和细胞内神经原纤维缠结,并伴有大脑中神经元的丧失。β-淀粉样肽(Aβ)是老年斑的主要成分,被认为在AD的发生和发展中起因果作用。多项证据表明,氧化应激增强和炎症在AD的发病机制或进展中起重要作用。本研究旨在探讨4-羟基-3-甲氧基肉桂酸乙酯(FAEE),一种具有抗氧化和抗炎活性的酚类化合物,对Aβ(1-42)诱导的氧化应激和神经毒性的保护作用。我们假设FAEE的结构将促进自由基清除并可能诱导保护性蛋白。Aβ(1-42)降低细胞活力,这与自由基形成增加、蛋白质氧化(蛋白质羰基、3-硝基酪氨酸)、脂质过氧化(4-羟基-2-反式壬烯醛)和诱导型一氧化氮合酶增加相关。用FAEE预处理原代海马培养物可显著减轻Aβ(1-42)诱导的细胞毒性、细胞内活性氧积累、蛋白质氧化、脂质过氧化和诱导型一氧化氮合酶的诱导。用Aβ(1-42)处理神经元会增加血红素加氧酶-1和热休克蛋白72的水平。与对Aβ(1-42)诱导的氧化应激的细胞应激反应一致,FAEE处理增加了血红素加氧酶-1和热休克蛋白72的水平,它们可能以协调的方式受氧化应激调节,并在神经元细胞对Aβ(1-42)诱导的毒性的细胞保护中起关键作用。这些结果表明,FAEE通过直接调节氧化应激和诱导保护性基因对Aβ(1-42)毒性发挥保护作用。这些发现表明,FAEE可能对AD和其他氧化应激相关疾病的治疗具有潜在重要性。